P3 Health Partners ROE 2020-2024 | PIII

Current and historical return on equity (ROE) values for P3 Health Partners (PIII) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
P3 Health Partners ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-12-31 $-0.14B $0.08B -107.24%
2024-09-30 $-0.10B $0.12B -71.40%
2024-06-30 $-0.07B $0.17B -42.86%
2024-03-31 $-0.07B $0.15B -78.59%
2023-12-31 $-0.06B $0.14B -119.37%
2023-09-30 $-0.13B $0.19B -916.36%
2023-06-30 $-0.12B $-0.14B 901.82%
2023-03-31 $-0.27B $0.00B -564.21%
2022-12-31 $-0.27B $0.01B -236.84%
2022-09-30 $-0.25B $0.08B -135.91%
2022-06-30 $-0.27B $0.11B -167.92%
2022-03-31 $-0.14B $0.26B -106.77%
2021-12-31 $-0.16B $0.27B -231.97%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.060B $1.500B
P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.307B 54.29
Hims & Hers Health (HIMS) United States $13.112B 136.23
Tempus AI (TEM) United States $10.781B 0.00
IRhythm Technologies (IRTC) United States $4.503B 0.00
Inspire Medical Systems (INSP) United States $4.415B 68.98
Privia Health (PRVA) United States $3.036B 207.50
Enovis (ENOV) United States $2.041B 11.38
Clover Health Investments (CLOV) United States $1.735B 0.00
Schrodinger (SDGR) United States $1.706B 0.00
Phreesia (PHR) United States $1.529B 0.00
Omnicell (OMCL) United States $1.315B 23.21
Azenta (AZTA) United States $1.223B 56.83
10x Genomics (TXG) United States $1.125B 0.00
Fulgent Genetics (FLGT) United States $0.610B 0.00
Butterfly Network (BFLY) United States $0.569B 0.00
Talkspace (TALK) United States $0.500B 149.50
Veradigm (MDRX) United States $0.482B 0.00
Claritev (CTEV) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.368B 816.67
Health Catalyst (HCAT) United States $0.286B 0.00
Nyxoah SA (NYXH) Belgium $0.212B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.207B 0.00
EUDA Health Holdings (EUDA) Singapore $0.147B 0.00
Pulmonx (LUNG) United States $0.138B 0.00
American Well (AMWL) United States $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.090B 0.00
CareCloud (CCLD) United States $0.086B 3.27
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.067B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) Netherlands $0.039B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00